Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VYD2311 in Long-COVID or Post-Vaccination Syndrome
NCT07899346Phase 2Not yet recruiting
- Sponsor
- Invivyd
- Start
- Oct 2026
- Primary completion
- Jun 2027
01
Overview
A Phase 2 trial of VYD2311 in post-COVID-19 condition (PCC), Post-vaccination syndrome (PVS), sponsored by Invivyd. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
VYD2311
03
Conditions
post-COVID-19 condition (PCC)Post-vaccination syndrome (PVS)
Beyond the preview
Go deeper on NCT07899346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07899346.